Our Mission

At Resilience, we are dedicated to developing innovative, first-in-class therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma related disorders.

About Resilience

At Resilience, we are dedicated to developing innovative, first-in-class therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma related disorders.

In the Trenches

Jeff Sabados – President

Kim Seth – Board of Director

Madhu Balachandran – Strategy and Operations

Greg Dombal – Clinical Operations Advisor

Steve Targum – Chief Medical Officer

Murray Stein – Chief Medical Advisor

Kerry Ressler – Chief Science Advisor

Alex Constan – Toxicology

Jason Fuller – Board of Director

William “Mo” Cowan – Strategic Advisor

Gregg Beloff – Chief Finance Officer

Frank Yocca – Strategic Advisor

Retsina Meyer – cofounder

Brad Geddes – cofounder

Veronica Weiner – cofounder

Eric Nestler – Scientific Advisor

Ann Rasmusson – Scientific Advisor

Emer Leahy – preclinical team

Taleen Hanania – preclinical team

Anthony Choo – preclinical team

Vadim Alexandrov – preclinical team

Work With Us

Developing therapeutics for anxiety and trauma related disorders is considered to be one of the most difficult challenges facing healthcare globally and yet it’s not getting the attention it needs. We are looking for the best neuroscience drug discovery leaders to join our world-class team and take on this challenge. We value people that are “All In, All The Time” – teammates that will dedicate themselves to research and each other, building lasting friendships and making a difference in patients’ lives.